| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
19 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-08-17 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The Update on the Commercial Rollout of CompuFlo® Epidural System in the Second Quarter
of 2020
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today provided an update on the commercial rollout of CompuFlo® Epidural System in
the second quarter ended June 30, 2020.
The Company’s primary focus remains commercialization of the CompuFlo® Epidural System,
and the Issuer is moving ahead aggressively towards this goal. Although the Company
experienced temporary setbacks due to COVID-19 with hospitals on complete lockdown,
The Board of Directors of the Company is pleased to report that the sales and business
development pipeline is expanding. The Company in late-stage discussions with a number
of premier hospitals in the U.S. Moreover, the CathCheck™ technology has resonated
well, given its ability to minimize contact between the patient and provider, which
is especially important during the COVID-19 pandemic. Importantly, the CompuFlo® Epidural
System is fully validated in terms of safety, efficacy and economics. For these reasons,
The Board of Directors of the Company is confident as ever that our technology will
become the new standard of care.
During the second quarter of 2020 the Company’s parent Milestone Scientific Inc. raised
gross proceeds of approximately $19.7 million from the sale of Milestone Scientific's
common stock and warrants. The Board of Directors of the Company believes that the
financing from its parent provides the Issuer with a substantial runway to help mitigate
the risks related to COVID-19, as well as additional resources to accelerate sales
and marketing activities around the CompuFlo Epidural System.
|
|
|
RB_ASO: The Update on the Commercial Rollout of CompuFlo® Epidural System in the Second Quarter
of 2020
